accessibility menu, dialog, popup

UserName
Viewing profile as user:

Fluorobenzenes

Organic compounds considered aryl halides that consist of a phenyl group with a fluorine atom substitution in the following structure: C₆H₅F.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (1)
  • (1)
  • (1)
  • (59)
  • (2)
  • (2)
  • (4)

special interests

  • (61)

Search Within Results
Keyword Search:
1 – 15 of 75 results
1

MEDCHEMEXPRESS LLC GAMMA-SECRETASE MODULATOR 2 10
SDP

501873877 GAMMA-SECRETASE MODULATOR 2 10

ENCOMPASS_PREFERRED
2

Medchemexpress LLC 10-[3-(dimethylamino)-2-methylpropyl]phenothiazine-2-carbonitrile | 3546-03-0 | MFCD00868180 | 99.4% | C19H21N3S | 10MG
SDP

Cyamemazine is a phenothiazine-class neuroleptic used in research for its anxiolytic and antipsychotic properties. It functions as a serotonin receptor antagonist and is supplied as solid reference standards and DMSO solutions for pharmacology and biochemical assays. Chemical identifiers: CAS 3546-03-0; formula C19H21N3S; mol wt 323.46 g·mol⁻1.

  • Phenothiazine-class neuroleptic with anxiolytic and antipsychotic activity.
  • Antagonist at 5-HT3, 5-HT2A, and 5-HT2C receptors.
  • Available as solid standards and 10 mM DMSO solution for assay preparation.
  • High purity suitable for research use (99.4%).
  • Includes RP-HPLC documentation for quality verification.

ENCOMPASS_PREFERRED
3

Medchemexpress LLC Soticlestat | 1429505-03-2 | 99.83% | 373.45 | 10 MG
SDP

Soticlestat (TAK-935; OV935) is a first-in-class, potent, selective, and orally active cholesterol 24-hydroxylase (CH24H) inhibitor with potential for epilepsy syndromes research.

  • It is for research use only, not intended for human use.
  • It inhibits the catalytic activity of human cholesterol 24-hydroxylase (CH24H) in a concentration-dependent manner with an IC50 of 4.5 nM.
  • Treatment with soticlestat lowers brain 24S-hydroxycholesterol in a dose-dependent manner.
  • It substantially reduces premature deaths of APP/PS1-Tg mice at a dose lowering brain 24S-hydroxycholesterol by approximately 50%.
  • It can suppress potassium-evoked extracellular glutamate elevations in the hippocampus.

ENCOMPASS_PREFERRED
4

Medchemexpress LLC C17H11Br2NO2S2 | 893449-38-2 | 99.1% | 485.21 | 10 MG
SDP

PRL-3 Inhibitor I is a potent PRL-3 inhibitor with an IC50 of 0.9 μM. It demonstrates reduced invasion in cell-based assays.

  • Potent PRL-3 inhibitor with an IC50 of 0.9 μM.
  • Reduces invasion in cell-based assay.
  • For research use only.

ENCOMPASS_PREFERRED
5

Sigma Aldrich Fine Chemicals Biosciences GPR35 Agonist, Compound 10 >=98% (HPLC) | 123021-85-2 | MFCD01835940 | 5MG

GPR35 Agonist, Compound 10 >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 279.27 | 123021-85-2 | MFCD01835940 | 5MG

ENCOMPASS
6

Sigma Aldrich Fine Chemicals Biosciences GPR35 Agonist, Compound 10 >=98% (HPLC) | 123021-85-2 | MFCD01835940 | 25MG

GPR35 Agonist, Compound 10 >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 279.27 | 123021-85-2 | MFCD01835940 | 25MG

ENCOMPASS
7

eMolecules​ Ethyl (2-bromo-4-fluorophenoxy)acetate | 1842-10-0 | MFCD11174614 | 1g

Oakwood Chemical | Ethyl (2-bromo-4-fluorophenoxy)acetate | 1g | 537705490 | 097727 | | 1842-10-0 | MFCD11174614 | 277.089 | C10H10BrFO3

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool

ENCOMPASS_PREFERRED
8

Medchemexpress LLC Abemaciclib metabolite M18 | 2704316-81-2 | 98.01% | 10 MG
SDP

Abemaciclib metabolite M18 (LSN3106729) is a metabolite of Abemaciclib and acts as a CDK inhibitor with antitumor activity. It has been utilized in conjunction with a CRBN ligand to engineer a PROTAC CDK4/6 degrader. The primary mechanism of action for CDK4/6 inhibitors involves the inhibition of retinoblastoma (RB) protein phosphorylation, leading to the induction of cell cycle arrest.

  • Acts as a CDK inhibitor with antitumor activity.
  • Utilized in conjunction with a CRBN ligand to engineer a PROTAC CDK4/6 degrader.
  • Inhibits retinoblastoma (RB) protein phosphorylation.
  • Induces cell cycle arrest.
  • Promotes T-cell persistence and increases immunologic memory in mice that receive tumor-specific CD8+ T cells.
  • Appears as an off-white to light yellow solid.

ENCOMPASS_PREFERRED
9

Medchemexpress LLC CDK12-IN-2 | 2244987-03-7 | 99.4% | 532.64 | 10 MG
SDP

CDK12-IN-2 is a potent, selective, and nanomolar CDK12 inhibitor with good physicochemical properties. It also acts as a strong CDK13 inhibitor because CDK13 is the closest homologue of CDK12. It demonstrates excellent kinase selectivity for CDK12 over CDK2, 9, 8, and 7. This compound inhibits the phosphorylation of Ser2 in the C-terminal domain of RNA polymerase II and can be used as an excellent chemical probe for functional studies of CDK12.

  • Potent, selective, and nanomolar CDK12 inhibitor
  • Strong CDK13 inhibitor
  • Excellent kinase selectivity over CDK2, 9, 8, and 7
  • Inhibits the phosphorylation of Ser2 in the C-terminal domain of RNA polymerase II
  • Can be used as an excellent chemical probe for functional studies of CDK12

ENCOMPASS_PREFERRED
10

eMolecules​ 4-BIPHENYL-4'-FLUORO-CARBOXYLIC ACID | 5731-10-2 | 5G | Purity: 98%

AstaTech | 4-BIPHENYL-4'-FLUORO-CARBOXYLIC ACID | 5G | MFCD01631909

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool

ENCOMPASS_PREFERRED
11

Medchemexpress LLC 2-Selenouracil | 16724-03-1 | 98.0% | 175.05 | 10 MG
SDP

2-Selenouracil is a specialized photosensitizer used for photodynamical therapy.

  • Specialized photosensitizer for photodynamical therapy.
  • Targets reactive oxygen species (ROS).
  • Involved in immunology/inflammation, metabolic enzyme/protease, and NF-κB pathways.
  • Powder storage at -20°C for 3 years or 4°C for 2 years.
  • In solvent storage at -80°C for 6 months or -20°C for 1 month.
  • Soluble in ethanol (2.5 mg/mL with ultrasonic) and slightly soluble in DMSO (< 1 mg/mL with ultrasonic, warming, and heating to 60°C).
  • For research use only.

ENCOMPASS_PREFERRED
12

Medchemexpress LLC NAZ2329 | 2809469-05-2 | 99.0% | 501.56 | C21H18F3NO4S3 | 10 MG
SDP

NAZ2329 is a cell-permeable small-molecule inhibitor of receptor-type protein tyrosine phosphatases PTPRZ and PTPRG supplied for research applications. It is characterized by micromolar inhibitory activity and is provided as a solid with recommended formulations for in vivo use.

  • CAS number 2809469-05-2; molecular formula C21H18F3NO4S3; molecular weight 501.56.
  • Purity 99.02% as supplied.
  • Targets PTPRZ (IC50 = 7.5 μM) and PTPRG (IC50 = 4.8 μM); shows activity against other PTP family members.
  • Solubility: DMSO 100 mg/mL; in vivo formulation examples and protocols available.
  • Storage: powder -20°C (up to 3 years); in solvent -80°C (up to 6 months).
  • For research use only; not for clinical use or sale to patients.

ENCOMPASS_PREFERRED
13

Medchemexpress LLC BCATc Inhibitor 2 10mg | 406191-34-2 | 418.77 g/mol | C16H10ClF3N2O4S | 10 MG
SDP

BCATc Inhibitor 2 is a selective inhibitor of cytosolic branched-chain aminotransferase (BCATc/BCAT1) used as a research tool in studies of branched-chain amino acid metabolism and neurodegenerative disease mechanisms. Reported IC50 values include 0.2 μM (rat cytosolic rBCATc), 0.8 μM (human cytosolic hBCATc), and 3.0 μM (rat mitochondrial rBCATm). The compound is supplied in high-purity solid and DMSO solution formats for laboratory research.

  • Selective inhibitor of cytosolic branched-chain aminotransferase (BCATc).
  • Reported IC50s: 0.2 μM (rBCATc), 0.8 μM (hBCATc), 3.0 μM (rBCATm).
  • High purity (99.28%).
  • Molecular formula C16H10ClF3N2O4S; molecular weight 418.77 g/mol.
  • Suitable for in vitro biochemical and cell-based assays.

ENCOMPASS_PREFERRED
14

Medchemexpress LLC Jnj 303 | 878489-28-2 | >98.0% | 440.98 | C21H29ClN2O4S | 10 MG
SDP

JNJ 303 is a synthetic research compound that selectively blocks delayed-rectifier Kv (IKs) potassium currents with reported IC50 ≈ 64 nM. It is used in preclinical studies related to diabetes, obesity, and central nervous system research. The compound has molecular formula C21H29ClN2O4S and molecular weight 440.98 g·mol⁻¹.

  • Potent IKs channel blocker (IC50 ≈ 64 nM).
  • High purity suitable for research (>98.0% HPLC).
  • Small-scale packaging for preclinical studies (1-10 mg).
  • Applicable to diabetes, obesity, and central nervous system studies.
  • Molecular weight 440.98 g·mol⁻¹; formula C21H29ClN2O4S.

ENCOMPASS_PREFERRED
15

Medchemexpress LLC 2-propenamide, N-[3-[2-[[4-[2-(dimethylamino)ethoxy]-2-methoxyphenyl]amino]...], trifluoroacetate | 2753348-63-7 | 99.4% | 628.60 | C30H31F3N6O6 | 10 MG
SDP

EGFR-IN-1 TFA is an orally active, irreversible small-molecule inhibitor selective for L858R/T790M mutant forms of the epidermal growth factor receptor (EGFR). It potently inhibits gefitinib-resistant EGFR mutants and demonstrates antiproliferative activity in mutant EGFR cell lines, making it suitable for cellular assays and preclinical research.

  • High mutant selectivity for L858R/T790M.
  • Irreversible mode of inhibition.
  • Potent antiproliferative activity in cell models.
  • Supplied as a trifluoroacetate salt for stability.
  • Intended for in vitro and preclinical research use.

ENCOMPASS_PREFERRED